Ocugen OCGN
NASDAQ OCGN
$1.36 +0.01 (+0.74%)
At close: Sep 4, 2026 · 4:00 PM EDT

Ocugen (OCGN) Current Assets (2014 - 2026)

Ocugen's (OCGN) quarterly Current Assets came in at $38.6 million in Q1 2026, down 12.31% YoY from $44.0 million in Q1 2025, and up 58.39% on a QoQ basis from $24.3 million in Q4 2025.

Analysis

Ocugen (OCGN) Current Assets (2014 - 2026) Analysis & Trends

Ocugen (OCGN) has 13 years of Current Assets data on file, last reported at $38.6 million in Q1 2026.

  • Quarterly Current Assets fell 12.31% year-over-year to $38.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38.6 million (down 12.31% YoY) and the FY2025 annual result came in at $24.3 million, down 60.54% from the prior year.
  • Current Assets grew to $38.6 million in Q1 2026, from $24.3 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $138.0 million in Q1 2022 to a low of $18.6 million in Q2 2024.
  • A 5-year average of $61.9 million and a median of $44.0 million in 2025 frame the typical range for Current Assets.
  • Annual changes were most pronounced in 2022 — Current Assets soared 168.77% — and 2024, when it plunged 74.65%.
  • Tracing OCGN's Current Assets over 5 years: stood at $98.5 million in 2022, then tumbled by 56.37% to $43.0 million in 2023, then jumped by 43.54% to $61.7 million in 2024, then plunged by 60.54% to $24.3 million in 2025, then jumped by 58.39% to $38.6 million in 2026.
  • The last three Current Assets figures came in at $38.6 million (Q1 2026), $24.3 million (Q4 2025), and $37.6 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 12.54 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 18.45 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 8.07 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.82 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.03 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 7.22 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 4.62 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 1.76 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.63 Bn
10 Ocugen 458.91 Mn 358.81 Mn - 106.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 106.72 Mn
Mar 31, 2026 38.55 Mn
Dec 31, 2025 24.34 Mn
Sep 30, 2025 37.64 Mn
Jun 30, 2025 32.88 Mn
Mar 31, 2025 43.96 Mn
Dec 31, 2024 61.68 Mn
Sep 30, 2024 40.67 Mn
Jun 30, 2024 18.62 Mn
Mar 31, 2024 30.00 Mn
Dec 31, 2023 42.97 Mn
Sep 30, 2023 56.56 Mn
Jun 30, 2023 73.45 Mn
Mar 31, 2023 84.40 Mn
Dec 31, 2022 98.49 Mn
Sep 30, 2022 107.50 Mn
Jun 30, 2022 122.57 Mn
Mar 31, 2022 138.03 Mn
Dec 31, 2021 102.65 Mn
Sep 30, 2021 113.45 Mn